Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Int J Gynecol Cancer. 2020 Nov 11;31(2):177–184. doi: 10.1136/ijgc-2020-001893

Table 3:

Survival analysis by Cox regression (univariate analysis) of parameters that influence overall survival in FIGO IB substages

StageIB1 Stage 1B2 Stage 1B3
Variable Overall
survival
HR
95% CI p Overall
survival
HR
95% CI p Overall
survival
HR
95% CI p
Age 1.11 0.23-5.26 0.88 1.51 0.41-5.51 0.52 1.61 0.34-7.53 0.54
Surgical treatment 1.48 0.72-3.02 0.27 9.70 0.01-999.99 0.53 4.56 0.01-999.99 0.85
HPV status 4.67 0.94-23.25 0.05 1.99 0.52-7.53 0.30 2.42 0.47-12.35 0.28
Silva pattern 2.25 0.63-8.10 0.21 3.10 0.56-16.95 0.19 10.87 0.002-74039.22 0.59
Histologic grade 2.64 0.92-7.56 0.06 1.18 0.45-3.07 0.73 2.51 0.71-8.92 0.15
Lymph-vascular
invasion
3.24 0.77-13.62 0.10 2.68 0.82-8.76 0.10 2.10 0.25-17.67 0.49
Precursor lesions 2.26 0.50-10.10 0.28 1.60 0.46-5.55 0.45 1.70 0.28-10.37 0.56
Lymph node metastases 6.05 1.51-24.25 0.011 2.43 0.64-9.19 0.18 7.77 0.70-86.02 0.09

FIGO, International Federation of Gynecology and Obstetrics; HPV, human papillomavirus